Literature DB >> 11257603

Comparison of Bcl-2 to a Bcl-2 deletion mutant for mammalian cells exposed to culture insults.

B Figueroa1, T M Sauerwald, A J Mastrangelo, J M Hardwick, M J Betenbaugh.   

Abstract

Apoptosis has been found to occur in bioreactors as a result of environmental stresses. The overexpression of bcl-2 is a widely used strategy to limit the induction of apoptosis in mammalian cell cultures. In this study, the effectiveness of wild-type Bcl-2 was compared to a Bcl-2 mutant lacking the nonstructured loop domain in two commercially prominent cell lines, Chinese hamster ovary (CHO) and baby hamster kidney (BHK) cells. The generation of a DNA "ladder" and condensation of chromatin indicated that apoptosis occurred in these cell lines following Sindbis virus infection and serum deprivation. When cells were engineered to overexpress the bcl-2 mutant, cell death due to Sindbis virus was inhibited in a concentration-dependent manner. Furthermore, the Bcl-2 mutant provided increased protection as compared to wild-type Bcl-2 following two model insults, Sindbis virus infection and serum deprivation. Total production for a heterologous protein encoded on the Sindbis virus was increased in cell lines expressing the Bcl-2 variants compared to the parental cell line. In order to understand the reasons for the improved anti-apoptosis properties of the mutant, wild-type Bcl-2 and mutant Bcl-2 were examined by Western blot following each model insult. Wild-type Bcl-2 was observed to degrade into a 23 kDa fragment following both Sindbis virus infection and serum withdrawal in both cell lines, while the mutant Bcl-2 protein was not degraded during the same period. The processing of Bcl-2 was found to correlate with reduced cell viabilities following the two external insults to suggest that Bcl-2 degradation may limit its ability to inhibit apoptosis. These studies indicate that the cells regulate anti-apoptosis protein levels and these processing events can limit the effectiveness of cell death inhibition strategies in mammalian cell culture systems. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257603     DOI: 10.1002/bit.1053

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  8 in total

1.  Directed evolution of mammalian anti-apoptosis proteins by somatic hypermutation.

Authors:  Brian S Majors; Gisela G Chiang; Nels E Pederson; Michael J Betenbaugh
Journal:  Protein Eng Des Sel       Date:  2011-12-09       Impact factor: 1.650

2.  Using cell engineering and omic tools for the improvement of cell culture processes.

Authors:  Darrin Kuystermans; Britta Krampe; Halina Swiderek; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2007-02-24       Impact factor: 2.058

3.  Enhanced transient recombinant protein production in CHO cells through the co-transfection of the product gene with Bcl-xL.

Authors:  Matthew P Zustiak; Lisa Jose; Yueqing Xie; Jianwei Zhu; Michael J Betenbaugh
Journal:  Biotechnol J       Date:  2014-05-08       Impact factor: 4.677

4.  Proteomic analysis of Chinese hamster ovary cells.

Authors:  Deniz Baycin-Hizal; David L Tabb; Raghothama Chaerkady; Lily Chen; Nathan E Lewis; Harish Nagarajan; Vishaldeep Sarkaria; Amit Kumar; Daniel Wolozny; Joe Colao; Elena Jacobson; Yuan Tian; Robert N O'Meally; Sharon S Krag; Robert N Cole; Bernhard O Palsson; Hui Zhang; Michael Betenbaugh
Journal:  J Proteome Res       Date:  2012-10-05       Impact factor: 4.466

Review 5.  Recent advances in mammalian protein production.

Authors:  Ashok D Bandaranayake; Steven C Almo
Journal:  FEBS Lett       Date:  2013-12-06       Impact factor: 4.124

6.  An improved in vitro and in vivo Sindbis virus expression system through host and virus engineering.

Authors:  Toey Nivitchanyong; Yien Che Tsai; Michael J Betenbaugh; George A Oyler
Journal:  Virus Res       Date:  2009-02-05       Impact factor: 3.303

7.  Regulating apoptosis in mammalian cell cultures.

Authors:  Nilou Arden; M J Betenbaugh
Journal:  Cytotechnology       Date:  2006-07-01       Impact factor: 2.058

8.  Protection of hybridoma cells against apoptosis by a loop domain-deficient Bcl-xL protein.

Authors:  J Charbonneau; E Gauthier
Journal:  Cytotechnology       Date:  2001-09       Impact factor: 2.058

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.